Identifying and Treating PAH: Impacting Patient Outcomes in the Primary Care Setting
This conference is designed for primary care physicians, family medicine specialists, internists, pediatricians, nurse practitioners, nurses, physician assistants, pharmacists, registered dietitians, certified diabetes educators, and other related healthcare professionals involved in primary care.
After completing this activity, participants should be able to
- Describe PAH symptomatology, risk factors, and diagnostic criteria to facilitate rapid disease identification
- Analyze the pharmacotherapeutic properties of available agents for the treatment of PAH and the latest clinical data surrounding their optimal use
- Incorporate guideline-recommended PAH treatment and referral strategies into primary care settings
This on-demand webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity (Practical Updates in Primary Care 2021; May 13-15, July 15-17, September 23-25, November 11-13, 2021) are not eligible to receive credit for this enduring webcast.
Release date: January 14, 2022
Expiration date: January 14, 2023
Estimated time to complete: 0.75 hour
There is no fee associated with this activity.
For questions regarding this educational activity, please call 609-371-1137.
The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to email@example.com.
In support of improving patient care, HMP Global is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
HMP Global designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards .75 contact hour.
This activity is approved for .75 contact hour (0.075 CEU) of continuing pharmacy education (UAN JA0006201-0000-22-007-H01-P ).
This educational activity is a knowledge-based activity.
ACPE Credit Policy
Your official record of ACPE credit will be generated through the CPE Monitor System. The certificate printed from this website after completing the evaluation for this activity is for personal tracking purposes only.
Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. Please note that you must complete the activity evaluation within 60 days of a live activity or within 60 days of beginning the evaluation for an enduring activity. Under ACPE Policy, HMP Education will not be able to report your activity completion to CPE Monitor after this 60-day period.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education, may contact Samantha Conforti, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at firstname.lastname@example.org or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint. If the participant is unsatisfied with the response, an appeal to the Associate Director, Greaton Sellers, Accreditation and Compliance, can be requested for a second level of review. Mr. Sellers can be contacted via phone at 609-371-1137, by email at email@example.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520.
Financial Disclosure and Conflicts of Interest
HMP Global is an independent provider of continuing medical education. HMP Global has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Global is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
HMP Global has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
The faculty has reported the following:
Michael J. Bloch Research Support–Recor; Consultant/Honoraria–Recor, Medtronic, Amgen, Esperion, Janssen, Amarin, Bristol Myers Squibb
Peter Oettgen has nothing to disclose in relation to this activity.
Preventive Cardiologist Cardiology Division Beth Israel Deaconess Medical Center
Associate Professor Harvard Medical School Boston, MA
Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California
HMP Global planners and staff include Ms. Bielar, Ms. Browne, Ms. Conforti, Ms. Duda, Mr. Harper, Ms. Hines, Ms. Johnson, Mr. Robbin, Mr. Sellers, and Ms. Tong
No HMP Global planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
HMP Global protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Global and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
HMP Global maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2022 by HMP Global. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Global.
This activity is supported by an independent educational grant from Actelion.